Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags LILLY DRN Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotech and Pharmaceuticals Biotechnology Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Market Outlook Europe Markets World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Market Outlook World Markets Tesla Inc
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Health care industry Social issues Health & Science
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Europe Markets Novo Nordisk A/S Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags AstraZeneca PLC Business Health & Science
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Business Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Health care industry Pharmaceuticals Retail
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Novo Nordisk A/S Science Dexcom Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Markets Investing
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Breaking News: Markets Markets Pharmaceuticals
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Health & Science Business Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Business News Novo Nordisk A/S Biotechnology
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Zealand Pharma A/S Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags LILLY DRN Business News Biotechnology
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Business Susser Petroleum Partners LP Vistra Corp
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health care industry Social issues Health & Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Deere & Co Volvo AB Bosch Ltd
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Pfizer Inc Companies Pharmaceuticals
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Novo Nordisk A/S Hims & Hers Health Inc Health & Science
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Breaking News: Business US: News LILLY DRN
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Pharmaceuticals Europe Economy Business
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags LILLY DRN Novo Nordisk A/S Science
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Palantir Technologies Inc stocks Business
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Health & Science Business Science
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Compagnie Financiere Richemont SA Breaking News: Business Retail industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.